SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-064848
Filing Date
2018-10-31
Accepted
2018-10-31 06:03:41
Documents
74
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-19027_110q.htm 10-Q 1555980
2 EX-31.1 a18-19027_1ex31d1.htm EX-31.1 13061
3 EX-31.2 a18-19027_1ex31d2.htm EX-31.2 13059
4 EX-32.1 a18-19027_1ex32d1.htm EX-32.1 7569
5 EX-32.2 a18-19027_1ex32d2.htm EX-32.2 7568
  Complete submission text file 0001104659-18-064848.txt   8157975

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT uthr-20180930.xml EX-101.INS 2096074
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20180930.xsd EX-101.SCH 61855
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20180930_cal.xml EX-101.CAL 68410
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20180930_def.xml EX-101.DEF 254883
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT uthr-20180930_lab.xml EX-101.LAB 573440
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20180930_pre.xml EX-101.PRE 411532
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 181148584
SIC: 2834 Pharmaceutical Preparations